Remove Clinical Trials Remove Containment Remove Packaging Remove Pharma Companies
article thumbnail

European Commission vs Big Pharma, or profit vs access?  

Drug Discovery World

Moreover, an extra six months of RDP for drugs with full comparator clinical trials (rather than showing only that a drug is no worse than the standard of care). However, stakeholders should be aware that the leaked review contains no such analysis.

article thumbnail

Q&A: The IND Journey Phase I – Navigating Success

Advarra

The sponsor is the pharmaceutical company conducting the trial. If you mean using a different contract research organization (CRO) for the different phases of clinical trials – that’s different. For good clinical practice (GCP), refer to ICH E6 (R2) Section 5 and address all quality elements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Russia’s focus on domestic pharma production could shield it from sanctions’ effects

Pharmaceutical Technology

Russia is an already insular country and its worldview has tended to be self-contained, but this has hardened in the face of recent sanctions and counter-sanctions imposed during the war with Ukraine. Several global pharma companies have already withdrawn their support following Russia’s invasion of Ukraine, which began on 24 February.

article thumbnail

Leading API biologics (cell, gene, vaccine and virus) companies in contract marketing

Pharmaceutical Technology

Pharmaceutical Technology has listed some of the top API biologics companies in contract marketing based on our intel, insights and decades-long experience in the sector. The download contains detailed information on the providers and their services and solutions, alongside contact details to aid your purchasing or hiring decision.

Gene 100
article thumbnail

Rising demand for pediatric dosage forms requires reformulation, expertise, and to-scale manufacturing capabilities

Pharmaceutical Technology

In many cases, pharma companies select a contract development and manufacturing organisation (CDMO) to develop products versus doing the work themselves for reasons related to cost, convenience, and capacity. In one specific case, Cambrex developed a PDF containing two APIs in suspension in an 80/20 ratio. Faster to market.